- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TGTX
Recent news which mentions TGTX
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 10, 2023
From Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
From Benzinga
From Benzinga
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 10, 2023
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
Top 5 Health Care Stocks That May Collapse In February
February 13, 2023
From Benzinga
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
February 08, 2023
From Benzinga
Here's How Much $100 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
February 07, 2023
Tickers
TGTX
From Benzinga
Here's How Much $1000 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
January 19, 2023
Tickers
TGTX
From Benzinga
'A Class Action Lawsuit Against TG Therapeutics Has Been Dismissed'
January 13, 2023
Tickers
TGTX
From Benzinga
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
January 03, 2023
From Benzinga
From Benzinga
Why TG Therapeutics Stock Was a Solid Winner This Week
December 30, 2022
Tickers
TGTX
From Motley Fool
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
December 30, 2022
From Benzinga
Shaw Communications, Enovix And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 30, 2022
From Benzinga
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
December 29, 2022
Tickers
TGTX
From Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 29, 2022
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know
December 29, 2022
Tickers
TGTX
From Benzinga
B of A Securities Maintains Underperform Rating for TG Therapeutics: Here's What You Need To Know
December 29, 2022
Tickers
TGTX
From Benzinga
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday
December 29, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.